Efficacy of Cryopreserved Recombinant Alteplase for Declotting Thrombosed Central Catheters

Important drug warning. January 25, 1999. The Food and Drug Administration [cited 1999 Oct 13]. Available at: URL: http://www.fda.gov/cber/ltr/abb012599.htm.

ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. Am J Hosp Pharm 1993;50: 2386–98.

Gale GB O'Connor DM Chu JY Stanley D . Restoring patency of thrombosed catheters with cryopreserved urokinase. JPEN J Parenter Enteral Nutr 1984;8: 298–9.

Atkinson JB Bagnall HA Gomperts E . Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters. JPEN J Parenter Enteral Nutr 1990;14: 310–1.

Haire WE Atkinson JB Stephens LC Kotulak GD . Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: A double-blinded, randomized trial. Thromb Haemost 1994;72: 543–7.

Package insert. Abbokinase Open-Cath (urokinase). North Chicago, IL: Abbott Laboratories, August 1994.

Callis KA Cullinane AM Horne MK III . Bioactivity of cryopreserved alteplase solutions. Am J Health Syst Pharm 1999;53: 2056–7.